简体中文 | 繁體中文 | English

Products & Services News

2019-01-09 15:30 Toshiba Announces 16TB MG08 Series Hard Disk Drives
2019-01-09 15:14 Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.
2019-01-09 14:33 INVECAS Announces World's First HDMI® 2.1 with HDCP2.3 Chip & IP Solutions for TV, AVR, Soundbar and STB
2019-01-09 10:16 WaveOptics and Wistron Form Strategic Partnership to Build AR Wearables
2019-01-09 10:07 Active-Semi’s First Wearable PMIC in the ActiveCiPSTM Series
2019-01-09 10:04 Bose Introduces QuietComfort Road Noise Control
2019-01-09 09:51 Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours
2019-01-08 18:07 FLIR Launches Second Generation Thermal Camera for Self-Driving Cars and New Thermal Handheld for Automotive Repair
2019-01-08 17:42 IBC2019 Technical Papers Submission is Now Open
2019-01-08 16:16 Ascend Performance Materials Declares Force Majeure on HMD
2019-01-08 12:20 Solasia Initiates Phase III Program for PledOx® in Japan
2019-01-08 12:10 Toshiba Develops DNN Hardware IP for Image Recognition AI Processor ViscontiTM5 for Automotive Driver Assistance Systems
2019-01-07 20:21 Velodyne Lidar to Present Breakthrough Technology for Autonomy and Driver Assistance at Consumer Electronics Show (CES) 2019
2019-01-07 16:47 ICBC Selects Gemalto Contactless Payment Cards to Accelerate China’s Digital Payment Transformation
2019-01-07 16:41 intoPIX Introduces the New JPEG XS Standard at CES
2019-01-07 16:26 ExaGrid, Provider of Intelligent Hyperconverged Storage for Backup, Reports Record Annual Revenue for 2018
2019-01-07 14:51 Velodyne Lidar Showcases a Wide Array of Never-Before-Seen Products at CES
2019-01-07 09:55 Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna
2019-01-04 17:53 CES 2019 Pitch Competition Featuring Shark Tank’s Daymond John Presented by CTA Foundation, AARP
2019-01-04 16:46 Takeda Announces Multiple Cell Therapy Collaborations to Advance the Company’s Novel Immuno-Oncology Portfolio